Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
about
Targeting MicroRNAs in Cancer Gene Therapy.An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.miRNAs: micro-managers of anticancer combination therapies.SASP regulation by noncoding RNA.Long non-coding RNAs involved in autophagy regulation.
P2860
Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@en
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@nl
type
label
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@en
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@en
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic strategy with arti ...... diffuse large B-cell lymphoma.
@en
P2093
Haihua Qian
Jianmin Wang
Jianmin Yang
Miaoxia He
Xianmin Song
Xinying Zhao
Xuejing Lin
P2860
P304
49143-49155
P356
10.18632/ONCOTARGET.9237
P407
P577
2016-05-09T00:00:00Z